Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo

Neuropharmacology

Volumn 62, Issue 7, 2012, Pages 2328-2336

  Bosier, Barbara ^a   Muccioli, Giulio G ^a   Mertens, Birgit ^b   Sarre, Sophie ^b   Michotte, Yvette ^b   Lambert, Didier M ^a   Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Agonist selective coupling; Dopamine; G protein; GPCR; Tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CATECHOLAMINE; DEXANABINOL; DOPAMINE; DRONABINOL; RIMONABANT; TYROSINE 3 MONOOXYGENASE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; DRUG EXPOSURE; DRUG PENETRATION; DRUG TISSUE LEVEL; EX VIVO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR OCCUPANCY; REGULATORY MECHANISM;

EID: 84859101738     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.02.003     Document Type: Article

References (50)

1. V.M. Andre, C. Cepeda, D.M. Cummings, E.L. Jocoy, Y.E. Fisher, Y.X. William, and M.S. Levine Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids Eur. J. Neurosci. 31 2010 14 28
2. D.W. Bonhaus, L.K. Chang, J. Kwan, and G.R. Martin Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses J. Pharmacol. Exp. Ther. 287 1998 884 888 (Pubitemid 29131596)
3. A. Bonnin, R. de Miguel, J.C. Rodriguez-Manzaneque, J.J. Fernandez-Ruiz, A. Santos, and J.A. Ramos Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids Brain Res. Dev. Brain Res. 81 1994 147 150 (Pubitemid 24246422)
4. B. Bosier, E. Hermans, and D. Lambert Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor Br. J. Pharmacol. 155 2008 24 33
5. B. Bosier, E. Hermans, and D.M. Lambert Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression Biochem. Pharmacol. 77 2009 216 227
6. B. Bosier, S. Sarre, I. Smolders, Y. Michotte, E. Hermans, and D.M. Lambert Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists Neuropharmacology 59 2010 503 510
7. B. Bosier, S. Tilleux, M. Najimi, D.M. Lambert, and E. Hermans Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line J. Neurochem. 102 2007 1996 2007 (Pubitemid 47329272)
8. R. Cachope, K. Mackie, A. Triller, J. O'Brien, and A.E. Pereda Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids Neuron 56 2007 1034 1047 (Pubitemid 350251118)
9. A.K. Cadogan, S.P. Alexander, E.A. Boyd, and D.A. Kendall Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum J. Neurochem. 69 1997 1131 1137 (Pubitemid 27364833)
10. J.F. Cheer, K.M. Wassum, M.L. Heien, P.E. Phillips, and R.M. Wightman Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats J. Neurosci. 24 2004 4393 4400 (Pubitemid 38608150)
11. J. Fernandez-Ruiz, M. Hernandez, and J.A. Ramos Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders CNS Neurosci. Ther. 16 2010 e72 e91
12. Fišar, Z. Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase. Prog. Neuropsychopharmacol. Biol. Psychiatry, in press.
13. T. Georgieva, S. Devanathan, D. Stropova, C.K. Park, Z. Salamon, G. Tollin, V.J. Hruby, W.R. Roeske, H.I. Yamamura, and E. Varga Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling Eur. J. Pharmacol. 581 2008 19 29
14. A. Giuditta, J.T. Chun, M. Eyman, C. Cefaliello, A.P. Bruno, and M. Crispino Local gene expression in axons and nerve endings: the glia-neuron unit Physiol. Rev. 88 2008 515 555 (Pubitemid 351520087)
15. M. Glass, and J.K. Northup Agonist selective regulation of g proteins by cannabinoid CB1 and CB2 receptors Mol. Pharmacol. 56 1999 1362 1369
16. S.J. Govaerts, E. Hermans, and D.M. Lambert Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors Eur. J. Pharm. Sci. 23 2004 233 243 (Pubitemid 39369878)
17. M. Herkenham, A.B. Lynn, B.R. De Costa, and E.K. Richfield Neuronal localization of cannabinoid receptors in the basal ganglia of the rat Brain Res. 547 1991 267 274
18. M. Hernandez, F. Berrendero, I. Suarez, L. Garcia-Gil, M. Cebeira, K. Mackie, J.A. Ramos, and J. Fernandez-Ruiz Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme Brain Res. 857 2000 56 65 (Pubitemid 30107790)
19. A. Higuera-Matas, F. Botreau, O.N. Del, M. Miguens, O. Olias, G.L. Montoya, C. Garcia-Lecumberri, and E. Ambrosio Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain Eur. Neuropsychopharmacol. 20 2010 895 906
20. A.G. Hohmann, and M. Herkenham Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study Synapse 37 2000 71 80 (Pubitemid 30366503)
21. O.D. Howes, A.J. Montgomery, M.C. Asselin, R.M. Murray, I. Valli, P. Tabraham, E. Bramon-Bosch, L. Valmaggia, L. Johns, M. Broome, P.K. McGuire, and P.M. Grasby Elevated striatal dopamine function linked to prodromal signs of schizophrenia Arch. Gen. Psychiatry 66 2009 13 20
22. B.D. Hudson, T.E. Hebert, and M.E. Kelly Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor Mol. Pharmacol. 77 2010 1 9
23. P. Huot, and A. Parent Dopaminergic neurons intrinsic to the striatum J. Neurochem. 101 2007 1441 1447 (Pubitemid 46848839)
24. M.J. Hurley, D.C. Mash, and P. Jenner Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR Eur. J. Neurosci. 18 2003 2668 2672 (Pubitemid 37452683)
25. P. Izurieta-Sanchez, S. Sarre, G. Ebinger, and Y. Michotte Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats Eur. J. Pharmacol. 353 1998 33 42 (Pubitemid 28352286)
26. F. Javoy-Agid, E.C. Hirsch, S. Dumas, C. Duyckaerts, J. Mallet, and Y. Agid Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study Neuroscience 38 1990 245 253 (Pubitemid 20334937)
27. J. Jelsing, A.M. Galzin, E. Guillot, M.P. Pruniaux, P.J. Larsen, and N. Vrang Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2 Brain Res. Bull. 78 2009 202 210
28. M.D. Julian, A.B. Martin, B. Cuellar, D.F. Rodriguez, M. Navarro, R. Moratalla, and L.M. Garcia-Segura Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia Neuroscience 119 2003 309 318 (Pubitemid 36577432)
29. A. Kastner, E.C. Hirsch, M.T. Herrero, F. Javoy-Agid, and Y. Agid Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease J. Neurochem. 61 1993 1024 1034 (Pubitemid 23241241)
30. I. Katona, and T.F. Freund Endocannabinoid signaling as a synaptic circuit breaker in neurological disease Nat. Med. 14 2008 923 930
31. T. Kenakin Agonist-receptor efficacy. II. Agonist trafficking of receptor signals Trends Pharmacol. Sci. 16 1995 232 238
32. T. Lau, and P. Schloss The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons Eur. J. Pharmacol. 578 2008 137 141 (Pubitemid 350309586)
33. J.E. Lauckner, B. Hille, and K. Mackie The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins Proc. Natl. Acad. Sci. U.S.A. 102 2005 19144 19149 (Pubitemid 43049580)
34. R. Maldonado, O. Valverde, and F. Berrendero Involvement of the endocannabinoid system in drug addiction Trends Neurosci. 29 2006 225 232
35. D.T. Malone, and D.A. Taylor Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats Br. J. Pharmacol. 128 1999 21 26 (Pubitemid 29425263)
36. S. Mukhopadhyay, and A.C. Howlett Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions Mol. Pharmacol. 67 2005 2016 2024 (Pubitemid 41007783)
37. C. O'Neill, A. Evers-Donnelly, D. Nicholson, K.M. O'Boyle, and J.J. O'Connor D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry J. Neurochem. 108 2009 545 551
38. V.C. Oropeza, M.E. Page, and E.J. Van Bockstaele Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex Brain Res. 1046 2005 45 54 (Pubitemid 40775873)
39. M.E. Page, V.C. Oropeza, S.E. Sparks, Y. Qian, A.S. Menko, and E.J. Van Bockstaele Repeated cannabinoid administration increases indices of noradrenergic activity in rats Pharmacol. Biochem. Behav. 86 2007 162 168 (Pubitemid 46274981)
40. S. Patel, and C.J. Hillard Cannabinoid-induced Fos expression within A10 dopaminergic neurons Brain Res. 963 2003 15 25 (Pubitemid 36126283)
41. F. Petitet, B. Jeantaud, P. Bertrand, and A. Imperato Cannabinoid penetration into mouse brain as determined by ex vivo binding Eur. J. Pharmacol. 374 1999 417 421 (Pubitemid 29313454)
42. M.K. Poddar, and W.L. Dewey Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes J. Pharmacol. Exp. Ther. 214 1980 63 67 (Pubitemid 10032383)
43. A.C. Riegel, and C.R. Lupica Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area J. Neurosci. 24 2004 11070 11078 (Pubitemid 40012966)
44. Y. Sakurai-Yamashita, Y. Kataoka, M. Fujiwara, K. Mine, and S. Ueki Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission Pharmacol. Biochem. Behav. 33 1989 397 400 (Pubitemid 19245527)
45. E.M. Schuman, J.L. Dynes, and O. Steward Synaptic regulation of translation of dendritic mRNAs J. Neurosci. 26 2006 7143 7146
46. I. Suarez, G. Bodega, J.A. Ramos, J.J. Fernandez-Ruiz, and B. Fernandez Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra Dev. Neurosci. 22 2000 253 263
47. B. Szabo, T. Muller, and H. Koch Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro J. Neurochem. 73 1999 1084 1089 (Pubitemid 29395465)
48. P. Szot, J.B. Leverenz, E.R. Peskind, E. Kiyasu, K. Rohde, M.A. Miller, and M.A. Raskind Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease Brain Res. Mol. Brain Res. 84 2000 135 140
49. J.D. Urban, W.P. Clarke, M. von Zastrow, D.E. Nichols, B. Kobilk4a, H. Weinstein, J.A. Javitch, B.L. Roth, A. Christopoulos, P.M. Sexton, K.J. Miller, M. Spedding, and R.B. Mailman Functional selectivity and classical concepts of quantitative pharmacology J. Pharmacol. Exp. Ther. 320 2007 1 13 (Pubitemid 46025713)
50. T. Wenger, G. Moldrich, and S. Furst Neuromorphological background of cannabis addiction Brain Res. Bull. 61 2003 125 128 (Pubitemid 36794269)